Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.78
+0.25007.08%
Volume:1.47M
Turnover:5.49M
Market Cap:414.95M
PE:-22.24
High:3.81
Open:3.54
Low:3.54
Close:3.53
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:84.96M
Volume Ratio:1.87
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.13
PE(LYR):-1.88

Loading ...

Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]